Keyword [antitumor agents] Result: 21 - 40 | Page: 2 of 3 |
21. | Design, Synthesis And Biological Evaluation Of MDM2 Ubiquitin Ligase Inhibitors As Antitumor Agents |
22. | Design, Synthesis, Biological Evaluation And SAR Studies Of Sorafenib Derivatives As Potential Antitumor Agents |
23. | Novel Water-soluble Photosensitizers As Antitumor Agents For Photodynamic Therapy |
24. | Studies Of Antitumor Iridium Hydrides Complexes And The Evolution Of Sortase A, Protein Modification With Unnatural Amino Acids |
25. | The Antiplatelet And Antithrombotic Effects Of DMXAA And The Mechanism Of NOD2 Potentiating Platelet Activation And Thrombosis |
26. | The Reseach On The LAT1-targeting Antitumor Agents And Its Pharmacokenetics |
27. | Structural Modification Of Camptothecin As Antitumor Agents |
28. | The Study Of Novel Antitumor Drugs And Corresponding Diagnostic Fluorescence Probe |
29. | Mechanisms Of Resistance To Antitumor Agents Targeting PI3K |
30. | Synthesis Of Podophyllotoxin Derivatives As Antitumor Agents |
31. | Synthesis, Biological Evaluation And Molecular Docking Studies Of 1,3,4-oxadiazole Derivatives As Potential Antitumor Agents |
32. | Novel 4-(4-substituted Amidobenzyl) Furan-2-(5H)-one Derivatives As Antitumor Agents Based On Topoisomerase ? Target |
33. | Functional Properties Of The Novel Antitumor Agents:NS,TAT-camptothecin Conjugates TAT-CPT/2CPT And[Cys-CPT2,9]penetratin In Antitumor Applications |
34. | Design,Synthesis And Biological Evaluation Of Multi-targeting Antitumor Agents And Proteolysis Targeting Chimera |
35. | Design,synthesis And Biological Evaluation Of Tubulin Inhibitors As Antitumor Agents Targeting The Colchicine Binding Site |
36. | Synthesis And Biological Evaluation Of Novel 7-hydroxy-4-phenylchromen-2-one-linked To Triazole Moieties As Potent Antitumor Agents |
37. | Design,Synthesis And Mechanisms Of Action Of Novel Harmine Derivatives As Potential Antitumor Agents |
38. | Design,Preparation And Activities Of New Dual-targeted Platinum Antitumor Agents |
39. | Design,Synthesis And Bioactivity Evaluation Of Antitumor Agents Targeting BRAF Kinase |
40. | Structure--activity relationship studies of hybrid antitumor agents for the treatment of non-small cell lung cancer |
|